相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Herve Tilly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma
Baptiste Eluard et al.
BLOOD (2022)
Cell cycle control in cancer
Helen K. Matthews et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)
An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma
Jasmine Goh et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Upfront therapy for diffuse large B-cell lymphoma: looking beyond R-CHOP
Brian T. Hill et al.
EXPERT REVIEW OF HEMATOLOGY (2022)
NF-κB Mutations in Germinal Center B-Cell Lymphomas: Relation to NF-κB Function in Normal B Cells
Laura Pasqualucci et al.
BIOMEDICINES (2022)
Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition
Yael Cohen-Sharir et al.
NATURE (2021)
Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and EP300 in diffuse large B-cell lymphoma
Man Nie et al.
CELL DEATH & DISEASE (2021)
Deciphering the mechanisms of CC-122 resistance in DLBCL via a genome-wide CRISPR screen
Zhongying Mo et al.
BLOOD ADVANCES (2021)
Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell Lymphoma
Kit Tong et al.
CLINICAL CANCER RESEARCH (2021)
The nuclear kinesin KIF18B promotes 53BP1-mediated DNA double-strand break repair
Janna Luessing et al.
CELL REPORTS (2021)
An efficient and effective method to identify significantly perturbed subnetworks in cancer
Le Yang et al.
NATURE COMPUTATIONAL SCIENCE (2021)
ShinyGO: a graphical gene-set enrichment tool for animals and plants
Steven Xijin Ge et al.
BIOINFORMATICS (2020)
mTOR at the nexus of nutrition, growth, ageing and disease
Grace Y. Liu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report
Stuart E. Lacy et al.
BLOOD (2020)
Kinesin Kif2C in regulation of DNA double strand break dynamics and repair
Songli Zhu et al.
ELIFE (2020)
Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasms
Michael Spinner et al.
BLOOD ADVANCES (2020)
Identification of BLNK and BTK as mediators of rituximab-induced programmed cell death by CRISPR screens in GCB-subtype diffuse large B-cell lymphoma
Emil Aagaard Thomsen et al.
MOLECULAR ONCOLOGY (2020)
Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia
Koichi Oshima et al.
NATURE CANCER (2020)
JACKS: joint analysis of CRISPR/Cas9 knockout screens
Felicity Allen et al.
GENOME RESEARCH (2019)
CRISPResso2 provides accurate and rapid genome editing sequence analysis
Kendell Clement et al.
NATURE BIOTECHNOLOGY (2019)
p53 mitotic centrosome localization preserves centrosome integrity and works as sensor for the mitotic surveillance pathway
Claudia Contadini et al.
CELL DEATH & DISEASE (2019)
The MTH1 inhibitor TH588 is a microtubule-modulating agent that eliminates cancer cells by activating the mitotic surveillance pathway
Nadia Gul et al.
SCIENTIFIC REPORTS (2019)
Microtubule end tethering of a processive kinesin-8 motor Kif18b is required for spindle positioning
Toni McHugh et al.
JOURNAL OF CELL BIOLOGY (2018)
A multiprotein supercomplex controlling oncogenic signalling in lymphoma
James D. Phelan et al.
NATURE (2018)
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Bjoern Chapuy et al.
NATURE MEDICINE (2018)
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
R. Schmitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Targeting deubiquitinase USP28 for cancer therapy
Xiaofang Wang et al.
CELL DEATH & DISEASE (2018)
Structural basis for ATP-dependent chromatin remodelling by the INO80 complex
Sebastian Eustermann et al.
NATURE (2018)
The ASCIZ-DYNLL1 axis promotes 53BP1-dependent non-homologous end joining and PARP inhibitor sensitivity
Jordan R. Becker et al.
NATURE COMMUNICATIONS (2018)
Cell death response to anti-mitotic drug treatment in cell culture, mouse tumor model and the clinic
Jue Shi et al.
ENDOCRINE-RELATED CANCER (2017)
Structural basis of human kinesin-8 function and inhibition
Julia Locke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
A New Mode of Mitotic Surveillance
Bramwell G. Lambrus et al.
TRENDS IN CELL BIOLOGY (2017)
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma
Anupama Reddy et al.
CELL (2017)
Tonic B-cell receptor signaling in diffuse large B-cell lymphoma
Ondrej Havranek et al.
BLOOD (2017)
Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas
Ryan D. Morin et al.
CLINICAL CANCER RESEARCH (2016)
A USP28-53BP1-p53-p21 signaling axis arrests growth after centrosome loss or prolonged mitosis
Bramwell G. Lambrus et al.
JOURNAL OF CELL BIOLOGY (2016)
53BP1 and USP28 mediate p53 activation and G1 arrest after centrosome loss or extended mitotic duration
Franz Meitinger et al.
JOURNAL OF CELL BIOLOGY (2016)
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
John G. Doench et al.
NATURE BIOTECHNOLOGY (2016)
Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models
Steffen Falgreen et al.
BMC CANCER (2015)
Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR
Wei Li et al.
GENOME BIOLOGY (2015)
Targeting Multidrug Resistance Protein 1 (MRP1, ABCC1): Past, Present, and Future
Susan P. C. Cole
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
Human B-cell cancer cell lines as a preclinical model for studies of drug effect in diffuse large B-cell lymphoma and multiple myeloma
Maria Bach Laursen et al.
EXPERIMENTAL HEMATOLOGY (2014)
Measuring error rates in genomic perturbation screens: gold standards for human functional genomics
Traver Hart et al.
MOLECULAR SYSTEMS BIOLOGY (2014)
Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library
Hiroko Koike-Yusa et al.
NATURE BIOTECHNOLOGY (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
Genetic Screens in Human Cells Using the CRISPR-Cas9 System
Tim Wang et al.
SCIENCE (2014)
Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles
Lauren M. Zasadil et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Kinesin-12 Differentially Affects Spindle Assembly Depending on Its Microtubule Substrate
Emma G. Sturgill et al.
CURRENT BIOLOGY (2013)
Aurora B and Kif2A control microtubule length for assembly of a functional central spindle during anaphase
Ryota Uehara et al.
JOURNAL OF CELL BIOLOGY (2013)
ATM Substrate Chk2-interacting Zn2+ Finger (ASCIZ) Is a Bi-functional Transcriptional Activator and Feedback Sensor in the Regulation of Dynein Light Chain (DYNLL1) Expression
Sabine Jurado et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Kif18A Uses a Microtubule Binding Site in the Tail for Plus-End Localization and Spindle Length Regulation
Lesley N. Weaver et al.
CURRENT BIOLOGY (2011)
Cancer cells display intra- and interline variation profound following prolonged exposure to antimitotic drugs
Karen E. Gascoigne et al.
CANCER CELL (2008)
Structural basis for understanding oncogenic p53 mutations and designing rescue drugs
Andreas C. Joerger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Dynamics of the p53-Mdm2 feedback loop in individual cells
G Lahav et al.
NATURE GENETICS (2004)
Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells
RE Davis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner
ZA Stewart et al.
ONCOGENE (2001)